Biosyntech Inc. Announces Changes to Board of Directors
LAVAL, QC, Jan. 26 /CNW/ - BioSyntech, Inc. (TSX: BSY), a biotechnology
company developing biotherapeutic thermogels for regenerative medicine, today
announced that Dr. Amine Selmani has resigned from its Board of Directors
effective January 23, 2009. Dr. Selmani is the founder of BioSyntech and was
its Chief Executive Officer from 1995 to 2004 and subsequently Chairman of the
Board of Directors until 2006. He has also managed BioSyntech's broad
intellectual property portfolio since the Company's inception. Dr Selmani will
remain available as an advisor to the Board of Directors.